BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 29587671)

  • 1. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
    Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
    BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
    Elliott MA; Tefferi A
    Curr Opin Hematol; 2014 Mar; 21(2):148-54. PubMed ID: 24335708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
    Mitsumori T; Komatsu N; Kirito K
    Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
    Tefferi A; Elliott M; Pardanani A
    Curr Opin Hematol; 2015 Mar; 22(2):171-6. PubMed ID: 25575036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
    Yin B; Chen X; Gao F; Li J; Wang HW
    Hematology; 2019 Dec; 24(1):538-543. PubMed ID: 31315541
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2014 Jun; 89(6):651-8. PubMed ID: 24845374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Szuber N; Orazi A; Tefferi A
    Am J Hematol; 2024 Apr; ():. PubMed ID: 38644693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
    Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
    Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Tyner JW; Gotlib J
    Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization.
    Castelli R; Cugno M; Gianelli U; Pancrazzi A; Vannucchi AM
    Pathol Res Pract; 2015 Apr; 211(4):341-3. PubMed ID: 25480691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2018 Aug; 93(4):578-587. PubMed ID: 29512199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].
    Cui Y; Li B; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1069-73. PubMed ID: 25543699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
    Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW
    Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal evolution in a chronic neutrophilic leukemia patient.
    Zhang QG; Wang J; Gong WY; Jing QC
    Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.